These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 10649254)

  • 1. Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma.
    Schrenk P; Rieger R; Shamiyeh A; Wayand W
    Cancer; 2000 Feb; 88(3):608-14. PubMed ID: 10649254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete versus selective axillary lymph node dissection in treatment of early breast carcinoma.
    Sharaf MF
    J Egypt Soc Parasitol; 2012 Apr; 42(1):207-16. PubMed ID: 22662610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group.
    Husted Madsen A; Haugaard K; Soerensen J; Bokmand S; Friis E; Holtveg H; Peter Garne J; Horby J; Christiansen P
    Breast; 2008 Apr; 17(2):138-47. PubMed ID: 17928226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shoulder-arm morbidity in patients with sentinel node biopsy and complete axillary dissection--data from a prospective randomised trial.
    Helms G; Kühn T; Moser L; Remmel E; Kreienberg R
    Eur J Surg Oncol; 2009 Jul; 35(7):696-701. PubMed ID: 18838245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
    Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
    Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment-related upper limb morbidity 1 year after sentinel lymph node biopsy or axillary lymph node dissection for stage I or II breast cancer.
    Rietman JS; Dijkstra PU; Geertzen JH; Baas P; de Vries J; Dolsma WV; Groothoff JW; Eisma WH; Hoekstra HJ
    Ann Surg Oncol; 2004 Nov; 11(11):1018-24. PubMed ID: 15525832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term morbidity of the upper limb after sentinel lymph node biopsy or axillary lymph node dissection for Stage I or II breast carcinoma.
    Rietman JS; Dijkstra PU; Geertzen JH; Baas P; De Vries J; Dolsma W; Groothoff JW; Eisma WH; Hoekstra HJ
    Cancer; 2003 Aug; 98(4):690-6. PubMed ID: 12910511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morbidity after conventional dissection of axillary lymph nodes in breast cancer patients.
    Soares EW; Nagai HM; Bredt LC; da Cunha AD; Andrade RJ; Soares GV
    World J Surg Oncol; 2014 Mar; 12():67. PubMed ID: 24670000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative morbidity of axillary lymph node dissection and the sentinel lymph node technique: implications for patients with breast cancer.
    Silberman AW; McVay C; Cohen JS; Altura JF; Brackert S; Sarna GP; Palmer D; Ko A; Memsic L
    Ann Surg; 2004 Jul; 240(1):1-6. PubMed ID: 15213610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
    Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A
    J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sentinel lymph node biopsy lowers the rate of lymphedema when compared with standard axillary lymph node dissection.
    Golshan M; Martin WJ; Dowlatshahi K
    Am Surg; 2003 Mar; 69(3):209-11; discussion 212. PubMed ID: 12678476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial.
    Mansel RE; Fallowfield L; Kissin M; Goyal A; Newcombe RG; Dixon JM; Yiangou C; Horgan K; Bundred N; Monypenny I; England D; Sibbering M; Abdullah TI; Barr L; Chetty U; Sinnett DH; Fleissig A; Clarke D; Ell PJ
    J Natl Cancer Inst; 2006 May; 98(9):599-609. PubMed ID: 16670385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy.
    Schijven MP; Vingerhoets AJ; Rutten HJ; Nieuwenhuijzen GA; Roumen RM; van Bussel ME; Voogd AC
    Eur J Surg Oncol; 2003 May; 29(4):341-50. PubMed ID: 12711287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sentinel lymph node biopsy results in less postoperative morbidity compared with axillary lymph node dissection for breast cancer.
    Burak WE; Hollenbeck ST; Zervos EE; Hock KL; Kemp LC; Young DC
    Am J Surg; 2002 Jan; 183(1):23-7. PubMed ID: 11869698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arm morbidity of axillary dissection with sentinel node biopsy versus delayed axillary dissection.
    Ballal H; Hunt C; Bharat C; Murray K; Kamyab R; Saunders C
    ANZ J Surg; 2018 Sep; 88(9):917-921. PubMed ID: 29392828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A patient- and assessor-blinded randomized controlled trial of axillary reverse mapping (ARM) in patients with early breast cancer.
    Beek MA; Gobardhan PD; Klompenhouwer EG; Menke-Pluijmers MB; Steenvoorde P; Merkus JW; Rutten HJ; Voogd AC; Luiten EJ
    Eur J Surg Oncol; 2020 Jan; 46(1):59-64. PubMed ID: 31402072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Axillary Lymph Node Dissection and Sentinel Lymph Node Biopsy on Upper Limb Morbidity in Breast Cancer Patients: A Systematic Review and Meta-Analysis.
    Che Bakri NA; Kwasnicki RM; Khan N; Ghandour O; Lee A; Grant Y; Dawidziuk A; Darzi A; Ashrafian H; Leff DR
    Ann Surg; 2023 Apr; 277(4):572-580. PubMed ID: 35946806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
    Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
    Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection.
    Ashikaga T; Krag DN; Land SR; Julian TB; Anderson SJ; Brown AM; Skelly JM; Harlow SP; Weaver DL; Mamounas EP; Costantino JP; Wolmark N;
    J Surg Oncol; 2010 Aug; 102(2):111-8. PubMed ID: 20648579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of side effects between sentinel lymph node and axillary lymph node dissection for breast cancer.
    Swenson KK; Nissen MJ; Ceronsky C; Swenson L; Lee MW; Tuttle TM
    Ann Surg Oncol; 2002 Oct; 9(8):745-53. PubMed ID: 12374657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.